Monahan Joseph — SEC Form 4 filings
SEC reporting owner CIK 1861790. 6 Form 4 filings on record with FilingPulse; latest filed 2025-03-04.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-05 to 2025-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | Chief Scientific Officer | 6 | — | — | 35 |
Form 4 filings — Monahan Joseph
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 50,000 · Option exercise (M): 10,925 · Tax withholding (F): 27,258 @ $1.99 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 10,925 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 7,500 · Option exercise (M): 14,750 · Tax withholding (F): 11,317 @ $2.48 · Option exercise (M): 7,500 (derivative) @ $0 · Option exercise (M): 14,750 (derivative) @ $0 · Grant/award (A): 83,900 (derivative) @ $0 · +1 more | EDGAR |
| 2025-01-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 73,750 · Tax withholding (F): 32,937 · Option exercise (M): 17,380 · Tax withholding (F): 8,914 · Option exercise (M): 73,750 (derivative) @ $0 · Grant/award (A): 52,667 (derivative) @ $0 · +1 more | EDGAR |
| 2024-12-12 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Gift (G): 15,000 @ $0 | EDGAR |
| 2024-03-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 50,000 · Tax withholding (F): 14,569 @ $1.24 · Option exercise (M): 10,925 · Tax withholding (F): 3,183 @ $1.24 · Option exercise (M): 12,500 · Tax withholding (F): 3,531 @ $1.24 · +3 more | EDGAR |
| 2024-02-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 7,500 · Tax withholding (F): 2,583 @ $1.20 · Option exercise (M): 7,500 (derivative) @ $0 · Grant/award (A): 206,500 (derivative) @ $0 · Grant/award (A): 59,000 (derivative) @ $0 · Grant/award (A): 147,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861790 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →